PubMed Health⌕ Search

Biomedical subjects

H Storck

Publications and source records attributed to H Storck.

At least 19 recordsLinked to original sources
PubMed1982

[Is malignant melanoma really radiation resistant?].

The efficiency of radiotherapy of malignant melanoma is discussed according to observations by other clinicians and ourselves. There is no proof that the melanoma is radiotherapy-resistant. The clinical radiosensitivity of human melanoma can be compared with the experimental hamster or mice melanoma or with the sensitivity of cultured melanoma cells. The possibility of increasing the efficiency of radiotherapy in the future by electroaffine sensitizers, fast electrons, or neutrons with a high LET and a small OER is mentioned.

Animals↗
PubMed1979

[The explained and the unexplained in dermatological immunology].

By means of classical allergologic and modern immunologic test methods, as well as recent knowledge about antigens and antibody reactions, some dermatoses can be classified with good probability into the allergy types of Coombs and Gell. In other dermatoses much remains unclear. The problems are discussed with regard to several dermatoses and attempts are made to explain some skin alterations by the mentioned immunologic types of reaction.

Adult↗
PubMed1978

[Triggering of immunologic reactions by Strehler's pressure wave therapy in patients with chronic venous insufficiency].

Thirteen patients with chronic venous insufficiency of the legs, mostly with ulcerations, were treated during four weeks by pressure wave therapy following the method of Strehler. Some parameters of circulation, blood, and immunology were controlled at the beginning, at the third, tenth, twentieth and fourtieth day. There was a tendency to normalization of hypo- and hypertension, of the blood calcium and kalium, and especially, there was a significant increase of IgG and C'4 during the treatment with decrease of the IgM. Other parameters did not show specific alterations. The mobilisation of edema by pressure wave therapy seems to arise an immunologic reaction, probably by activating antigens or antigen-antibody complexes.

Complement System Proteins↗
PubMed1977

Malignant melanoma.

Explore the source record for details and available documents.

History, 20th Century↗
PubMed1977

[Clinic, statistic and risik factors of the malignant melanoma (author's transl)].

The prognosis for malignant melanoma is dependent on the stage of the disease, sex, size respectively depth of penetration, structure (lentigo maligna melanoma, superficial spreading melanoma, nodular melanoma), location and age of the patient when the disease begins. The method of conventional treatment (X-ray then excision, excision then X-ray, X-ray alone, excision alone) is not important. The decisive factor is early diagnosis (histology) and early treatment (total excision of the tumor). The value of additional immunotherapy and chemotherapy in cases diagnosed early cannot yet be judged. Melanoma is rarer among colored races than among whites, and the frequency of the disease among Caucasians increases as one approaches the equator. Morbidity and mortality are rising throughout the world. The influence of factors such as trauma and sunlight is disputed.

Age Factors↗
PubMed1976

[Course and therapy of malignant melanoma].

The 3-, 5- and 10-year survival rates in 353 well documented cases of malignant melanoma in stages I, II and III are discussed in relation to condition of the patient when the disease was diagnosed, methods of treatment and the histological classes of CLARK and MIHM. The different forms of therapy (X-ray followed by excision, excision followed by X-ray, X-ray alone, excision alone) produce similar recovery rates. Significant differences observable are due to variations in the patients' condition (differences in the malignancy index). Histological classification confirms the benign nature of lentigo maligna melanoma (LMM) and superficial spreading melanoma (SSM) in comparison with nodular melanoma (NM).

Humans↗